Dear members of the HSGTRM, I wish you a happy and creative New Year 2022.
Τhe following announcement is made, just in case anyone of you is specifically interested. The field is wide and includes a high number of topics; if you have any questions, please write to me directly:
Special Issue on “Progress in Non-Viral Gene Transfer for Gene Therapy Applications”
Non-viral vectors for gene therapy, presenting a non-invasive to the genome approach, are emerging as the new generation of DNA vectors for Gene Therapy and I am currently editing a Special Issue on “Progress in Non-Viral Gene Transfer for Gene Therapy Applications” in the journal Genes (ISSN 2073-4425; IF 4.096). As the Guest Editor, I would like to invite you to contribute a paper on a pertinent topic.
I believe it is important that contributions derive from the whole spectrum of engagement, that is from groups with long and high standing in the field to those engaged in an intersection with a gene therapy topic, presenting valuable data and credible opinions, which will enhance our common understanding and increase the impact of this Special Issue.
Accordingly, I would be delighted if you would consider submitting a review or research article to this Issue. For further reading, please follow the link to the Special Issue website at:
The submission deadline is 20 June 2022. You may send your manuscript now or up until the deadline. Submitted papers should not be under consideration for publication elsewhere.
Genes is an online, peer-reviewed, open access journal, with more than 5000 published manuscripts, indexed in major scholarly databases (Scopus, SCIE, PubMed, MEDLINE, PMC, Embase, AGRIOLA and many other databases). As an online open access journal, papers published in Genes receive rapid publication, immediate accessibility, and high publicity. To support open access, Article Processing Charges (APC) of 2000 CHF currently apply to all accepted papers.